跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OZAWADE 18 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
OZAWADE 18 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
OZAWADE 18 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Bioprojet Pharma
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 11, 2021
Approval ID
28f5605140cb7399
Company
Bioprojet Pharma
Type
Standard
Approval Details
Approval Id
28f5605140cb7399
Drug Cima Aemps Name
OZAWADE 18 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1211546002
Holder Company Name
Bioprojet Pharma
Marketing Company Name
Bioprojet Pharma
Holder Company Detail Path
/organization/bioprojet-pharma
Marketing Company Detail Path
/organization/bioprojet-pharma
Authorization Date
2021-11-11
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
18 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Bioprojet Pharma
Company Detail Path
/organization/bioprojet-pharma
Company Information
Pharmaceutical Company Name
Bioprojet Pharma
Country Name
Belgium
City Name
unknown,unknown,country_be
Address
Unknown Belgian address
Active Ingredients
PITOLISANT HIDROCLORURO
20 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 11, 2021
Approval ID
28f5605140cb7399
Type
Standard
Back to CIMA-AEMPS Approvals
